crofelemer usan trade name mytesi antidiarrheal indicated symptomatic relief noninfectious diarrhea adult patients hivaids antiretroviral possible uses include diarrhea children acute infectious diarrhea diarrhea patients irritable bowel purified oligomeric proanthocyanidin dragons blood sap south american tree croton crofelemer treats symptoms disease used treat infectious diarrhea diarrhea caused infection digestive system bacterium virus parasite initially developed napo pharmaceuticals wholly owned subsidiary jaguar health inc phase iii clinical trial diarrhea hiv patients completed drug approved us food drug administration fda december drug taken orally works modulating cystic fibrosis transmembrane conductance regulator cftr calciumactivated chloride channel cacc two chloride ion channels luminal side gastrointestinal firstinclass antisecretory antidiarrheal mechanism action affect gastrointestinal motility unlike traditional antimotility drugs result channel regulation fewer chloride ions secreted gut decreases associated secretion sodium ions accompanying water thus improving stool consistency reducing frequency watery stools duration mechanism selective cftr cacc channels involved intestinal fluid secretion namely sodium potassium channels affected crofelemer camp calcium crofelemer minimally absorbed gut bloodstream mostly excreted crofelemer well tolerated adverse effects found clinical studies mild gastrointestinal effects level common adverse reactions upper respiratory tract infection bronchitis cough flatulence increased crofelemer oligomeric proanthocyanidin mixture primarily composed monomer units linked random sequence represented average degree polymerization oligomers ranges determined phloroglucinol degradation substance purified oligomeric proanthocyanidin sap correctly latex south american tree croton lechleri locally called sangre de grado sangre de drago one several plants producing bright red latex resin called dragons crofelemer complex mixture procyanidins prodelphinidins epicatechin epigallocatechin units per molecule resulting molecular mass crude plant latex c lechleri traditionally used south american medicine treatment diarrhea wounds inflammations tumors insect bites number chemicals isolated late tested cellular animal models example identifying taspine cicatrizant wound healing immunomodulatory antioxidative antiproliferative mutagenic effects dragons blood components also received attention scientific community purified oligomeric proanthocyanidin fraction first described name antiviral study testing treatment herpes simplex show crofelemer reported improve symptoms cholera toxin induced diarrhea crofelemer demonstrated reduction duration diarrhea frequency watery stools patients travelers patients crofelemer also shown benefit adult patients acute infectious diarrhea e coli patients moderate severe watery diarrhea vibrio cholerae crofelemer also shown improve abdominal pain discomfort patients diarrheapredominate irritable bowel eventually named crofelemer patented napo pharmaceuticals licensed glenmark pharmaceuticals exclusive development marketing rights emerging markets including salix pharmaceuticals exclusive development marketing rights north america european union japan subsequently napo sued salix terminated agreements salix glenmark alleging stalling drugs crofelemer completed phase iii trial approved december fda indication symptomatic relief noninfectious diarrhea patients hivaids antiretroviral drug substance manufactured glenmark pharmaceuticals manufactured mg delayedrelease tablets patheon pharmaceuticals inc napo pharmaceuticalscitation needed httpsenwikipediaorgwikicrofelemer